Launch of IBEF Publication ‘The Best of India in Pharmaceuticals’ at Innovation Awards, CPhI Worldwide

Share Article

The India Brand Equity Foundation (IBEF) publication "The Best of India in Pharmaceuticals" was launched at the Innovation awards at CPhI Worldwide. The coffee table book talks about the various opportunities available in domestic as well as the exports market.

The Best of India in Pharmaceuticals

Launch of IBEF publication "The Best of India in Pharmaceuticals"

The Best of India in Pharmaceuticals covers the government initiatives as well as the regulatory framework of India, making it a must-have for every company interested in the Indian pharmaceutical industry across the globe said Aparna D Sharma, CEO, IBEF

The India Brand Equity Foundation (IBEF) publication titled ‘The Best of India in Pharmaceuticals was released last evening at the Innovation Awards at CPhI Worldwide by Mr S R Rao, Commerce Secretary, Ministry of Commerce and Industry, Government of India, Mr Nik Rudge, Managing Director, UBM Live and Mr Andrew Pert, Brand Director, UBM Live.

Innovation Awards, a platform to recognise, celebrate and honour the companies that are breaking new ground in the pharmaceutical industry by CPhI provided a perfect platform for the release of this publication that covers the growth of the Indian pharmaceutical industry and at the same time, talks about the recent innovations by the Indian companies in the pharma space.

With a brief overview of the Indian pharmaceutical industry, the coffee table book talks about the current scenario in various segments of the Indian pharmaceutical market and opportunities available in the industry.

“The Best of India in Pharmaceuticals, highlighting the changing dynamics of the Indian pharmaceutical market, talks about the various opportunities available in domestic as well as the exports market. At the same time, the publication also covers the government initiatives as well as the regulatory framework of India, making it a must-have for every company interested in the Indian pharmaceutical industry across the globe,” said Aparna Dutt Sharma, Chief Executive Officer, IBEF.

Divided into ten detailed chapters covering all the broad segments of the Indian pharma sector like Biotechnology, Clinical Trials, Biosimilars, Probiotics, Neutraceuticals and Contract Manufacturing, the publication aims to highlight the strength of the Indian pharma sector and the key opportunities available across segments.

For further information please visit http://www.brandindiapharma.in

About IBEF
India Brand Equity Foundation is a Trust established by the Ministry of Commerce with the Confederation of Indian Industry (CII) as its associate. IBEF’s primary objective is to promote and create international awareness of the Made in India label in markets overseas and to facilitate the dissemination of knowledge of Indian products and services. IBEF is engaged in building Brand India. Towards this objective IBEF works closely with stakeholders across government and industry.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aditi Thakur
Follow us on
Visit website